Altered Ca


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
24 12 2021
Historique:
received: 26 11 2021
revised: 20 12 2021
accepted: 21 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 26 2 2022
Statut: epublish

Résumé

Over 95% of Polycythemia Vera (PV) patients carry the V617F mutation in the tyrosine kinase Janus kinase 2 (JAK2), resulting in uncontrolled erythroid proliferation and a high risk of thrombosis. Using mass spectrometry, we analyzed the RBC membrane proteome and showed elevated levels of multiple Ca

Identifiants

pubmed: 35011611
pii: cells11010049
doi: 10.3390/cells11010049
pmc: PMC8750512
pii:
doi:

Substances chimiques

Intermediate-Conductance Calcium-Activated Potassium Channels 0
KCNN4 protein, human 0
Proteome 0
JAK2 protein, human EC 2.7.10.2
Janus Kinase 2 EC 2.7.10.2
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-11-LABX-0051
Organisme : Agence Nationale de la Recherche
ID : ANR-11-IDEX-0005-02
Organisme : Agence Nationale de la Recherche
ID : ANR-18-IDEX-0001
Organisme : European Union
ID : European Union's Horizon 2020 Research and Innovation Program

Références

Br J Haematol. 2005 Apr;129(1):138-50
pubmed: 15801966
Blood Adv. 2020 Dec 22;4(24):6336-6341
pubmed: 33351129
Annu Rev Pathol. 2016 May 23;11:101-26
pubmed: 27193452
Cell Physiol Biochem. 2008;21(1-3):183-92
pubmed: 18209485
Haematologica. 2019 Nov;104(11):2200-2205
pubmed: 30948488
Blood. 2012 Aug 30;120(9):1908-15
pubmed: 22529292
Blood. 1992 Jan 1;79(1):52-7
pubmed: 1728320
Biochim Biophys Acta. 2016 Nov;1863(11):2758-2765
pubmed: 27566291
J Biol Chem. 2010 Dec 17;285(51):40252-65
pubmed: 20940306
Mol Cell Biol. 1990 Aug;10(8):3952-64
pubmed: 2196440
Immunity. 2004 Feb;20(2):153-65
pubmed: 14975238
Haematologica. 2014 Feb;99(2):267-75
pubmed: 23975182
Am J Physiol Cell Physiol. 2013 Dec 1;305(11):C1123-38
pubmed: 24048732
Blood. 2012 Jan 26;119(4):1036-44
pubmed: 22049517
Int Rev Cell Mol Biol. 2015;316:159-82
pubmed: 25805124
Nat Methods. 2014 Mar;11(3):319-24
pubmed: 24487582
Exp Hematol. 2017 Jun;50:53-76
pubmed: 28232234
Exp Hematol. 2004 Apr;32(4):360-4
pubmed: 15050746
Blood. 2002 Nov 1;100(9):3392-9
pubmed: 12384442
Cell Rep. 2013 Nov 27;5(4):926-32
pubmed: 24239357
Haematologica. 2019 May;104(5):e179-e183
pubmed: 30237269
Blood Adv. 2018 Oct 23;2(20):2646-2657
pubmed: 30327373
Haematologica. 2021 Aug 01;106(8):2246-2250
pubmed: 33596644
Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H347-55
pubmed: 20495145
Blood. 2013 Sep 26;122(13):2176-84
pubmed: 23823316
Blood. 2012 May 31;119(22):5265-75
pubmed: 22427201
PLoS One. 2017 Mar 1;12(3):e0173077
pubmed: 28249049
Biochim Biophys Acta. 1978 Sep 22;512(2):284-95
pubmed: 30483
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
J Cell Sci. 2012 Jan 15;125(Pt 2):340-9
pubmed: 22331356
Blood. 2013 Aug 22;122(8):1464-77
pubmed: 23863895
J Clin Oncol. 2005 Apr 1;23(10):2224-32
pubmed: 15710945
Blood Cells Mol Dis. 2015 Feb;54(2):170-6
pubmed: 25477265
Int J Mol Sci. 2013 May 08;14(5):9848-72
pubmed: 23698771
Haematologica. 2016 Sep;101(9):1054-64
pubmed: 27479815
Haematologica. 2018 Dec;103(12):1997-2007
pubmed: 30076174
Blood. 1977 Dec;50(6):987-93
pubmed: 922165
Cell Calcium. 2017 Jul;65:73-79
pubmed: 28216081
Bioelectrochemistry. 2002 Jan;55(1-2):71-4
pubmed: 11786344
Nature. 2013 Jul 4;499(7456):92-6
pubmed: 23748442
Exp Hematol. 2016 Apr;44(4):247-56.e12
pubmed: 26724640
Nature. 1982 Jul 29;298(5873):478-81
pubmed: 6283392
Exp Hematol. 2017 Jun;50:46-52
pubmed: 28238805
Oncogene. 2002 Oct 17;21(47):7137-46
pubmed: 12370803
Ann Hematol. 2011 Jul;90(7):747-58
pubmed: 21221583
J Biol Chem. 2011 Sep 30;286(39):34426-39
pubmed: 21828046
Nat Cell Biol. 2008 Mar;10(3):314-21
pubmed: 18264091
Blood. 2006 Aug 1;108(3):791-801
pubmed: 16861337
Mol Cancer Res. 2017 Jul;15(7):852-861
pubmed: 28314843
J Cell Biol. 2001 Jan 8;152(1):127-40
pubmed: 11149926
J Clin Invest. 1985 Oct;76(4):1605-12
pubmed: 3932468
Mediterr J Hematol Infect Dis. 2009 Dec 20;1(1):e2009024
pubmed: 21415994
Front Physiol. 2021 Oct 11;12:743094
pubmed: 34707512
Cell Calcium. 2011 Jul;50(1):54-61
pubmed: 21616535
Genesis. 2002 Dec;34(4):251-6
pubmed: 12434335
Front Physiol. 2017 Dec 12;8:977
pubmed: 29311949
Nat Protoc. 2009;4(5):698-705
pubmed: 19373234
Bioelectrochemistry. 2012 Oct;87:89-95
pubmed: 21890432
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Dev Cell. 2014 Sep 29;30(6):688-700
pubmed: 25241935
Am J Physiol Cell Physiol. 2012 Feb 15;302(4):C644-51
pubmed: 22173866
Haematologica. 2017 Jul;102(7):e241-e244
pubmed: 28385780

Auteurs

Ralfs Buks (R)

BIGR, UMR_S1134, Inserm, Université de Paris, F-75015 Paris, France.
Institut National de la Transfusion Sanguine, F-75015 Paris, France.
Laboratoire d'Excellence GR-Ex, F-75015 Paris, France.

Tracy Dagher (T)

Laboratoire d'Excellence GR-Ex, F-75015 Paris, France.
U1287, Inserm, Université Paris-Saclay, Gustave Roussy, F-94800 Villejuif, France.

Maria Giustina Rotordam (MG)

Nanion Technologies GmbH, 80339 Munich, Germany.
Theoretical Medicine and Biosciences, Medical Faculty, Saarland University, Kirrbergerstr. 100, DE-66424 Homburg, Germany.

David Monedero Alonso (D)

Laboratoire d'Excellence GR-Ex, F-75015 Paris, France.
Sorbonne Université, CNRS, UMR LBI2M, Station Biologique de Roscoff SBR, F-29680 Roscoff, France.

Sylvie Cochet (S)

BIGR, UMR_S1134, Inserm, Université de Paris, F-75015 Paris, France.
Institut National de la Transfusion Sanguine, F-75015 Paris, France.
Laboratoire d'Excellence GR-Ex, F-75015 Paris, France.

Emilie-Fleur Gautier (EF)

Laboratoire d'Excellence GR-Ex, F-75015 Paris, France.
Institut Imagine-INSERM U1163, Necker Hospital, Université de Paris, F-75015 Paris, France.
Proteomics Platform 3P5, Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104 Paris, France.

Philippe Chafey (P)

Proteomics Platform 3P5, Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104 Paris, France.

Bruno Cassinat (B)

Laboratoire d'Excellence GR-Ex, F-75015 Paris, France.
IRSL, U1131, INSERM, Université de Paris, F-75010 Paris, France.
Hôpital Saint-Louis, Laboratoire de Biologie Cellulaire, AP-HP, F-75010 Paris, France.

Jean-Jacques Kiladjian (JJ)

Laboratoire d'Excellence GR-Ex, F-75015 Paris, France.
IRSL, U1131, INSERM, Université de Paris, F-75010 Paris, France.
Centre d'Investigations Cliniques, Hôpital Saint-Louis, Université de Paris, F-75010 Paris, France.

Nadine Becker (N)

Nanion Technologies GmbH, 80339 Munich, Germany.

Isabelle Plo (I)

Laboratoire d'Excellence GR-Ex, F-75015 Paris, France.
U1287, Inserm, Université Paris-Saclay, Gustave Roussy, F-94800 Villejuif, France.

Stéphane Egée (S)

Laboratoire d'Excellence GR-Ex, F-75015 Paris, France.
Sorbonne Université, CNRS, UMR LBI2M, Station Biologique de Roscoff SBR, F-29680 Roscoff, France.

Wassim El Nemer (W)

BIGR, UMR_S1134, Inserm, Université de Paris, F-75015 Paris, France.
Institut National de la Transfusion Sanguine, F-75015 Paris, France.
Laboratoire d'Excellence GR-Ex, F-75015 Paris, France.
Etablissement Français du Sang PACA-Corse, F-13005 Marseille, France.
Aix Marseille Univ, EFS, CNRS, ADES, "Biologie des Groupes Sanguins", F-13005 Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH